Skip to content
10-Q/A

Quarterly Report

MOLECULAR PHARMACOLOGY (USA) LTD.

0001221508-13-000006

← back to feed
Filed
Feb 12, 2013 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2013 · Feb 5, 2013 111.55M sh
Operating Cash Flow Q2 2013 · Dec 31, 2012 −$59.78K
Operating Cash Flow Q2 2013 · Dec 31, 2012 −$114.48K
Operating Cash Flow Q2 2013 · Dec 31, 2012 −$1.99M
Operating Cash Flow Q2 2013 · Dec 31, 2011 −$61.25K
Operating Cash Flow Q2 2013 · Dec 31, 2011 −$91.98K
Cash And Equivalents Q2 2013 · Dec 31, 2012 $5.99K
Cash And Equivalents Q2 2013 · Jun 30, 2012 $2.57K
Stockholders Equity Q2 2013 · Dec 31, 2012 −$2.21M
Stockholders Equity Q2 2013 · Jun 30, 2012 −$2.08M
Total Liabilities Q2 2013 · Dec 31, 2012 $2.23M
Total Liabilities Q2 2013 · Jun 30, 2012 $2.09M
Current Assets Q2 2013 · Dec 31, 2012 $13.68K
Current Assets Q2 2013 · Jun 30, 2012 $8.84K
Net Income Q2 2013 · Dec 31, 2012 −$48.9K
Net Income Q2 2013 · Dec 31, 2012 −$100.99K
Net Income Q2 2013 · Dec 31, 2012 −$1.95M
Net Income Q2 2013 · Dec 31, 2011 −$54.47K
Net Income Q2 2013 · Dec 31, 2011 −$81.74K
Operating Income Q2 2013 · Dec 31, 2012 −$48.07K
Operating Income Q2 2013 · Dec 31, 2012 −$100.17K
Operating Income Q2 2013 · Dec 31, 2012 −$2.24M
Operating Income Q2 2013 · Dec 31, 2011 −$54.47K
Operating Income Q2 2013 · Dec 31, 2011 −$81.74K